Topper James N bought NAMS

March 26, 2024 · Form 4 insider transaction

Topper James N bought 8,429 shares of NewAmsterdam Pharma Company N.V. at $21.50 per share, a transaction worth $181.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
8,429
Price
$21.50
Total value
$181.2K
RoleDirector, 10% owner
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateMarch 26, 2024
Filing dateMarch 28, 2024
Shares owned after3,008,429
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

View the original Form 4 on SEC EDGAR